Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Center for clinical and translational research COVID-19 clinical trial committee: The development of a review and prioritization matrix during a pandemic

Journal of Clinical and Translational Science(2021)10.1017/cts.2021.4Source: DataRank Database

Center for clinical and translational research COVID-19 clinical trial committee: The development of a review and prioritization matrix during a pandemic is a research paper published in Journal of Clinical and Translational Science (2021). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.23)OA: goldTopics (27)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Lisa Richman Ballance,Antonio Abbate ORCID,Jesse C. Bain,Patricia J. Sime ORCID,F. Gerard Moeller ORCID

Live enrichment

PubMed:34192047 PMC:PMC8082134 OpenAlex:https://openalex.org/W3124396804

NCATS NIH HHS

Grant: UL1 TR002649

National Institutes of Health

Grant: 5UL1TR002649-02

Center for Clinical and Translational Research

FWCI

0.23

Citation Percentile

0.7%

Citation Trend

2023

goldLicense: cc-by-nc-sa

journalhttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/A4D6D8FAD92AC14BCB53561F45D01835/S2059866121000042a.pdf/div-class-title-center-for-clinical-and-translational-research-covid-19-clinical-trial-committee-the-development-of-a-review-and-prioritization-matrix-during-a-pandemic-div.pdf

publisherhttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/A4D6D8FAD92AC14BCB53561F45D01835/S2059866121000042a.pdf/div-class-title-center-for-clinical-and-translational-research-covid-19-clinical-trial-committee-the-development-of-a-review-and-prioritization-matrix-during-a-pandemic-div.pdf

publisherhttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/S2059866121000042

journalhttps://doi.org/10.1017/cts.2021.4

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34192047

Fields of Study

Health Systems, Economic Evaluations, Quality of LifeEthics in Clinical ResearchHealth and Medical Research Impacts03 medical and health sciences0302 clinical medicine

Keywords

Clinical trialPrioritizationPandemicResource (disambiguation)MedicineProtocol (science)Coronavirus disease 2019 (COVID-19)Process (computing)Process managementComputer scienceMedical educationBusinessDiseaseAlternative medicineInfectious disease (medical specialty)PathologyClinical researchTranslational ResearchCollaborationCtsaCovid-19R

Sustainable Development Goals

SDG 3: 3. Good health